GetTopicDetailResponse(id=c329103136f1, topicName=黃斑變性, introduction=黃斑變性, content=null, image=null, comments=3, allHits=1946, url=https://h5.medsci.cn/topic?id=103136, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=1788, tagList=[TagDto(tagId=1788, tagName=黃斑變性)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2188035, encodeId=ef9c218803569, content=<a href='/topic/show?id=c329103136f1' target=_blank style='color:#2F92EE;'>#黃斑變性#</a> <a href='/topic/show?id=a46a94293c9' target=_blank style='color:#2F92EE;'>#近視#</a> <a href='/topic/show?id=18a011132483' target=_blank style='color:#2F92EE;'>#BCVA#</a>, objectTitle=失明或視力障礙的“禍?zhǔn)住敝?！這類人群中，約有1/8人疾病進(jìn)展 | JAMA子刊, objectType=article, longId=813412, objectId=d6168134128a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/267914-eye.jpg, objectUrl=/article/show_article.do?id=d6168134128a, replyNumber=0, likeNumber=136, createdTime=2024-02-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=d6168134128a, moduleTitle=失明或視力障礙的“禍?zhǔn)住敝唬∵@類人群中，約有1/8人疾病進(jìn)展 | JAMA子刊, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d6168134128a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1241729, encodeId=a88b1241e2916, content=<a href='/topic/show?id=4399103e93a7' target=_blank style='color:#2F92EE;'>#抗血管新生#</a><a href='/topic/show?id=c329103136f1' target=_blank style='color:#2F92EE;'>#黃斑變性#</a>, objectTitle=中國臺(tái)灣專家共識(shí)：新生血管性年齡相關(guān)性黃斑變性的治療 , objectType=guider, longId=18540, objectId=48cf31c00259013e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=48cf31c00259013e, replyNumber=0, likeNumber=126, createdTime=2022-08-29, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48cf31c00259013e, moduleTitle=中國臺(tái)灣專家共識(shí)：新生血管性年齡相關(guān)性黃斑變性的治療 , moduleType=guider, hrefUrl=http://ermita.cn/guideline/show_article.do?id=48cf31c00259013e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1197849, encodeId=7ef2119e849fb, content=2022年結(jié)果，
IIb / III 期試驗(yàn)失敗了，表明1期結(jié)果并不能說明問題<a href='/topic/show?id=c329103136f1' target=_blank style='color:#2F92EE;'>#黃斑變性#</a>, objectTitle=新型抗VEGF抗體聚合物KSI-301治療濕性AMD、DME、RVO取得階段成果, objectType=article, longId=176439, objectId=b2ea1e643956, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201907/20190729181143698.jpeg, objectUrl=/article/show_article.do?id=b2ea1e643956, replyNumber=0, likeNumber=128, createdTime=2022-02-27, rootId=0, userName=醫(yī)者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2ea1e643956, moduleTitle=新型抗VEGF抗體聚合物KSI-301治療濕性AMD、DME、RVO取得階段成果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b2ea1e643956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1197848, encodeId=19b7119e848d8, content=http://ermita.cn/article/show_article.do?id=beb8299e4190
IIb / III 期試驗(yàn)失敗了，表明1期結(jié)果并不能說明問題<a href='/topic/show?id=c329103136f1' target=_blank style='color:#2F92EE;'>#黃斑變性#</a>, objectTitle=KSI-301治療濕性AMD、糖尿病性黃斑水腫和視網(wǎng)膜靜脈阻塞的Ib期臨床試驗(yàn)取得積極結(jié)果, objectType=article, longId=187876, objectId=f10618e87660, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/202002/20200212002322208.jpeg, objectUrl=/article/show_article.do?id=f10618e87660, replyNumber=0, likeNumber=117, createdTime=2022-02-27, rootId=0, userName=醫(yī)者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f10618e87660, moduleTitle=KSI-301治療濕性AMD、糖尿病性黃斑水腫和視網(wǎng)膜靜脈阻塞的Ib期臨床試驗(yàn)取得積極結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f10618e87660)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
